MarsBit published a lengthy opinion article arguing that Binance’s biggest threat is no longer a direct product challenge from Hyperliquid alone, but the passing of time in a market where liquidity, policy access and political alignment are increasingly linked. The piece says Binance’s absence from the U.S. Commodity Futures Trading Commission’s IAC meeting was a visible sign that the exchange is losing ground in Washington even as Hyperliquid builds policy infrastructure through the Hyperliquid Policy Center, or HPC. The article ties together several threads: Donald Trump’s inner circle, Witkoff’s reported involvement with WLFI, USD1’s relationship with Aster, Justin Sun’s defense of USDD, and Binance’s reported delays around restrictions connected to HTX. It argues that in the current cycle, crypto is being reshaped less by the old BTC-altcoin rotation and more by access to U.S. compliance channels, stablecoin liquidity and institutional influence. According to the author, Binance still has scale and trading depth, but that strength has become a source of pressure rather than insulation. The commentary says the exchange now faces a three-sided problem: preserving liquidity, securing regulatory access to the U.S. market, and avoiding being forced into explicit geopolitical alignment. Its final conclusion is blunt: Binance will not lose to Hyperliquid, but to time.

Gate’s latest market data showed strength across several names in its gStocks tokenized stock segment, with Direxion Daily Semiconductor Bear 3X Shares represented by SOXSG/USDT posting the largest 24-hour gain among the top movers at 2.82%. Coca-Cola’s KOG/USDT followed with a 0.81% rise, while Eli Lilly’s LLYG/USDT added 0.70% over the same period. The update was cited by Odaily. Gate said gStocks is continuing to expand its ecosystem of tokenized global equity assets to give users more ways to participate in the market. According to the platform, the product supports 24/7 trading, unified account management, and lower-entry participation. Gate also said users can use the offering to access popular global stocks with greater flexibility and combine digital assets with traditional securities in a single allocation path. The exchange added that it plans to keep adding more stock and ETF listings to broaden global asset allocation choices available through gStocks.

Eric Trump on Saturday denied claims that anyone was launching a new Trump-linked coin, calling the rumor fraudulent in a post on his blue-checkmarked X account. His message came after two X posts circulated a launch claim: one from Whale Scan at 2:39 p.m. ET saying “DONALD TRUMP IS OFFICIALLY ABOUT TO LAUNCH HIS NEW COIN,” and another at 3:03 p.m. ET describing a Robinhood Chain wallet that had received 290 ETH and was interacting with “WWW / ‘Truth Coin’ contracts.” Neither post cited an announcement, a ticker, a contract address, or a named token issuer. CoinGecko showed TRUMP at $2.47, up 37.9% over 24 hours, with a range of $1.79 to $3.60. MELANIA was at $0.1112, up 18.4%, in a $0.09085 to $0.1614 range. Both tokens were trading below their 24-hour highs while the rumor spread. Eric Trump’s only direct statement was categorical: “No one is launching any kind of coin.”

Moderna and Merck said their jointly developed mRNA melanoma vaccine trial met its goal, setting off a sharp rally in biopharma stocks. Moderna shares surged as much as 176.97% on Wednesday and closed at $174, marking the company’s biggest single-day gain on record, according to ABMedia. Merck also rose more than 12.60% to $152.20. The report said the vaccine candidate, Intismeran Autogene, used in combination with Merck’s Keytruda, reduced the risk of recurrence for some melanoma patients. Leerink Partners analyst Daina Graybosch called the Phase 3 trial result “historic.” ABMedia also said the move lifted shares of BioNTech, AbbVie, Amgen, Eli Lilly and Johnson & Johnson. The outlet added that Moderna’s latest progress came after weaker COVID-19 vaccine demand had left investors watching its transition strategy closely, while recent sector rotation had started bringing capital back into healthcare and biotech stocks.

Gate gStocks, the tokenized securities platform operated by Gate, saw several popular stock tokens extend gains, with the MiniMax token (MINIMAXG/USDT) rising 13.66% in the past 24 hours to $37.28, the top performer among the day's hot gStocks. The Direxion Semiconductor 3x Inverse ETF token (SOXSG/USDT) climbed 5.48% to $45.44, while the Eli Lilly token (LLYG/USDT) reached $1,174.35, up 4.09%. The latest moves come as trading activity in the technology innovation and pharmaceutical sectors remains active. The platform uses a 1:1 reserve mechanism, meaning each tokenized security is backed by an equivalent amount of the underlying native stock. It supports 24/7 trading, unified account management, fractional shares, and entry from as little as 1 USDT. This allows users to participate in global stock investment with greater flexibility while combining digital assets and traditional securities in one portfolio. As the tokenized securities ecosystem continues to expand, Gate gStocks plans to add more quality stock and ETF products, offering users a wider range of global asset allocation options.

BlockBeats on Aug. 3 compiled a list of 10 notable pre-market developments in U.S. equities, spanning geopolitics, Federal Reserve commentary, corporate updates, and tech pricing expectations. Iran foreign ministry spokesperson Baghaei said Tehran is not currently in talks with the United States and is instead in discussions with Oman over the Strait of Hormuz. New York Fed President John Williams said he remains optimistic that inflation pressures will ease gradually, but added the Fed would not hesitate to raise rates if needed to bring price pressures back to target. In pre-market trading, SpaceX briefly fell below $106, marking a record low. Samsung Electronics’ foundry division is expected to reach 100% capacity utilization in the second half of this year, up from an estimated 70% to 80% currently. Eli Lilly’s pancreatic cancer therapy received Breakthrough Therapy designation, while Italy’s Prysmian said Monday it is in advanced talks to acquire U.S. electrical manufacturer Atkore. Apple is also limiting how many security vulnerabilities external researchers can submit at one time after a surge in AI-generated reports strained its review process. Alibaba rose nearly 4% pre-market after Qwen released Qwen3.8-Max. Separately, Mark Gurman said iPhone prices are expected to increase by $100 to $200, and that a foldable iPhone could start at at least $2,000, or more.

ARK Invest analyst Lorenzo said Hyperliquid has reached a new point in its market mix, with real-world asset trading on HIP-3 exceeding crypto-native volume for the first time in a single week. According to the figures cited in the post, RWA accounted for 54% of total platform volume, and 61% of that RWA activity came from single-stock products. The article argues this shift points to a broader change in Hyperliquid’s positioning, from a crypto perpetuals venue to a round-the-clock multi-asset derivatives platform spanning equities, indices, commodities and FX. The write-up also stresses that the RWA products in question are synthetic perpetual contracts rather than tokenized securities. Traders get price exposure, typically margined in USDC, but do not receive actual stock ownership, voting rights or legal claims on the underlying assets. It distinguishes that model from true securities tokenization and notes the two paths carry different infrastructure, legal and operational requirements. At the same time, the piece flags a math issue in the original comparison between Hyperliquid’s HIP-3 RWA volume and the rest of the DEX perpetuals market, and says the claim cannot be directly derived from the numbers presented. It further examines what the trend could mean for HYPE, USDC and Circle, while outlining the current HIP-3 market map, where activity is concentrated in stocks, commodities and indices, with much of the volume attributed to the trade[XYZ] deployment.

Bitcoin rose 3.9% to $70,006, driving ETH, XRP, BNB, and Solana higher. Smaller altcoins like Derive DRV surged 68.9% leading gainers, with total market volume strong.